Scarica l'app Stockscreener
1.57
7.10%
-0.12
Dopo l'orario di chiusura:
1.59
0.02
+1.27%
Precedente Chiudi:
$1.69
Aprire:
$1.73
Volume 24 ore:
306.78K
Relative Volume:
2.01
Capitalizzazione di mercato:
$7.28M
Reddito:
$3.57M
Utile/perdita netta:
$-15.74M
Rapporto P/E:
-0.226
EPS:
-6.9481
Flusso di cassa netto:
$-15.77M
1 W Prestazione:
-9.25%
1M Prestazione:
-30.53%
6M Prestazione:
-82.56%
1 anno Prestazione:
-94.71%
Intervallo 1D:
$1.55
$1.79
Intervallo di 1 settimana:
$1.55
$1.82
Portata 52W:
$1.55
$42.00
Icecure Medical Ltd Stock (ICCM) Company Profile
Nome
Icecure Medical Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Compare ICCM vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
1.57 | 8.02M | 3.57M | -15.74M | -15.77M | -6.9481 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Icecure Medical Ltd Borsa (ICCM) Ultime notizie
Part of IceCure Medical (ICCM)'s proposed chairman grant depends on at least $6.5 million in financing. - Stock Titan
IceCure Medical regains Nasdaq bid price compliance - scanx.trade
ICCM Stock On Track For Best Day In Nearly 5 Years — What’s Driving The 200% Rally? - Stocktwits
ICCM Stock Price, Quote & Chart - ChartMill
IceCure sees Brazil adoption rise after FDA clearance - scanx.trade
IceCure Medical gets IRB approval for ProSense breast cancer study - scanx.trade
Icecure Medical H1FY26 Results: Revenue up 45% YoY to $1.8 million - scanx.trade
Full Transcript: Icecure Medical Q2 2026 Earnings Call - Benzinga
ICCM Q2 2026 Earnings: Wider-Than-Expected Loss as EPS Misses Consensus by More Than 100%Earnings Manipulation Risk - dars.gov.et
IceCure Secures China NMPA Approval for ProSense Cryoablation System - Yahoo Finance
ICCM Looks 89.8% Undervalued on GF Value™ Despite Challenging Fu - GuruFocus
Icecure Medical Receives Regulatory Approval to Market Prosense in China - marketscreener.com
IceCure Medical (ICCM) secures China nod for tumor-freezing cancer tool - Stock Titan
China approves a tumor-freezing system from IceCure - Stock Titan
IceCure Medical Ltd. (ICCM) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Icecure Medical Earnings Call Signals Early Growth Phase - TipRanks
IceCure and Scovas agree for ProSense distribution in Netherlands - Yahoo Finance
IceCure (ICCM) Results at a Glance: EPS Does Not Reach the Reported Estimate under the Current Snapshot; Post-Earnings: Shares Move 6.58% Down in Latest TradingTax Rate Impact - vinanet.vn
Icecure Medical Ltd. Signs Exclusive Distribution Agreement with Scovas Medical for Prosense Cryoablation Systems in the Netherlands - marketscreener.com
IceCure (ICCM) Earnings Report: Profit Per Share Falls Below Its Benchmark for the Current Session; Market Response - vinanet.vn
IceCure Medical (ICCM): Commercial Adoption Is Improving, but the Reimbursement and Scale Story Still Needs More Proof - AlphaStreet
ICCM Looks 87.8% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
IceCure says West Cancer Center IRB clears ChoICE breast cancer cryoablation study - Bitget
IceCure's ProSense Is First and Only for Low-Risk Breast Cancer With FDA Marketing Authorization - Stock Titan
Icecure Medical Ltd (ICCM) (Q2 2026) Earnings Call Highlights: R - GuruFocus
IceCure Medical (ICCM) Q2 2026 Earnings Call Transcript - AOL.ca
IceCure (ICCM) Earnings Report: EPS Misses Its Estimate under the Current Snapshot; Share Response - vinanet.vn
IceCure Medical Ltd. SEC Filing (Aug 19, 2026) - Stock Titan
IceCure Medical (ICCM) grants 131K RSUs to North America VP - Stock Titan
IceCure Medical : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
IceCure Medical (NASDAQ: ICCM) director lists no shares - Stock Titan
IceCure (NASDAQ: ICCM) VP now holds 106K shares and RSUs - Stock Titan
IceCure Medical (ICCM) awards COO 141K new RSUs - Stock Titan
IceCure Medical (NASDAQ: ICCM) adds 73,890 RSUs to VP HR stake - Stock Titan
IceCure Medical (ICCM) director Chan Vincent leaves board - Stock Titan
ICCM Looks 85.8% Undervalued on GF Value™ - GuruFocus
IceCure Medical director David Salton files initial beneficial ownership statement - Bitget
IceCure Medical (ICCM) expands 2024 employee share incentive reserve - Stock Titan
Armistice Capital (ICCM) reports 300,332 IceCure Medical shares under shared control - Stock Titan
Maxim Group Maintains Icecure Medical(ICCM.US) With Buy Rating, Cuts Target Price to $10 - Moomoo
IceCure Medical (ICCM) Earnings Call zum 2. Quartal 2026: Umsatz im 1. Halbjahr steigt um 45 % - TradingKey
IceCure Medical (ICCM) details 324,802-share warrant issuance and $9.7M potential proceeds - Stock Titan
New studies highlight FDA-approved ProSense cry... - pluang.com
Two papers examine tumor freezing beyond the primary breast tumor - Stock Titan
IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation - PR Newswire
IceCure Medical Q2 2026 Earnings Call Transcript - MarketBeat
IceCure Medical prices $5.5 million private placement at premium - scanx.trade
IceCure Medical Ltd Q2 2026 Earnings Call Summary - Yahoo Finance
IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year - GuruFocus
Earnings call transcript: IceCure Medical misses Q2 2026 estimates as shares fall - Investing.com
Icecure Medical Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Icecure Medical Ltd Azioni (ICCM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.26%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):